Mechanisms of monoclonal antibody therapy

I am currently studying and trying to differentiate the primary anti-tumor ‎mechanisms used by monoclonal antibodies in circulating malignant cells‎ versus solid tumors.

Kern DJ, James BR, Blackwell S, Gassner C, Klein C, Weiner GJ. GA101 induces NK-cell activation and antibody-dependent cellular cytotoxicity more effectively than rituximab when complement is present. Leuk Lymphoma. 2013 Nov;54(11):2500-5. doi: 10.3109/10428194.2013.781169. Epub 2013 Apr 16. PubMed PMID: 23452151; PubMed Central PMCID: PMC3957421.